Holen Sie sich die Stockscreener-App
105.54
1.10%
1.15
Handel nachbörslich:
105.33
-0.21
-0.20%
Schlusskurs vom Vortag:
$104.39
Offen:
$105.01
24-Stunden-Volumen:
117.34K
Relative Volume:
0.69
Marktkapitalisierung:
$583.10M
Einnahmen:
$249.13M
Nettoeinkommen (Verlust:
$6.71M
KGV:
87.40
EPS:
1.2076
Netto-Cashflow:
$39.58M
1W Leistung:
+7.53%
1M Leistung:
-1.05%
6M Leistung:
+32.87%
1J Leistung:
+4.88%
1-Tages-Spanne:
$103.61
$107.67
1-Wochen-Bereich:
$96.28
$107.67
52-Wochen-Spanne:
$55.45
$113.99
Mesa Laboratories Inc Stock (MLAB) Company Profile
Firmenname
Mesa Laboratories Inc
Sektor
Telefon
(303) 987-8000
Adresse
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
105.54 | 550.01M | 249.13M | 6.71M | 39.58M | 1.2076 |
COHR
Coherent Corp
|
333.36 | 77.17B | 6.60B | 452.58M | -538.24M | 2.0946 |
KEYS
Keysight Technologies Inc
|
313.86 | 59.83B | 6.09B | 1.07B | 1.36B | 6.0693 |
GRMN
Garmin Ltd
|
240.02 | 45.81B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
652.08 | 30.90B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
365.56 | 30.04B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-10-02 | Eingeleitet | JP Morgan | Neutral |
| 2019-12-04 | Eingeleitet | Jefferies | Buy |
| 2019-08-26 | Eingeleitet | Evercore ISI | Outperform |
| 2016-06-10 | Herabstufung | Sidoti | Buy → Neutral |
Alle ansehen
Mesa Laboratories Inc Aktie (MLAB) Neueste Nachrichten
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerDividend Growth Analysis - dars.gov.et
Enterprise value to EBITDA forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to book forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to sales forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Enterprise value to EBIT forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB) - TradingView
MLAB Forecast — Price Target — Prediction for 2027 - TradingView
Mesa Labs CFO John Sakys sells $253k in company stock - Investing.com UK
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com - Investing.com South Africa
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion - Investing.com UK
Mesa Labs CFO John Sakys sells $253k in company stock By Investing.com - Investing.com India
Mesa Labs CAO Crennen sells $39,559 in MLAB shares - Investing.com UK
Mesa Labs CAO Crennen sells $39,559 in MLAB shares By Investing.com - Investing.com South Africa
Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale - Stock Titan
Form 4 Mesa Laboratories Inc For: 23 June By Investing.com - Investing.com Canada
Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares - Stock Titan
Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale - Stock Titan
Form 144 MESA LABORATORIES INC /CO/ For: 22 June By Investing.com - Investing.com Nigeria
MLAB (NASDAQ: MLAB) files Rule 144 for 2,827 vested shares via Fidelity - Stock Titan
MLAB (NASDAQ: MLAB) insider sale notice — 2,516 shares disclosed - Stock Titan
Mesa Laboratories strategy in focus, NASDAQ shares trade in a niche health tech segment - AD HOC NEWS
MLAB SEC FilingsMesa Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan
Mesa Laboratories Inc (MLAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mesa Laboratories Inc (MLAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mesa Laboratories Inc (MLAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mesa Laboratories Inc (MLAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mesa Laboratories Inc (MLAB) Institutional Confidence - TradingKey
Mesa Laboratories Inc (MLAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mesa Laboratories Inc (MLAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mesa Laboratories (MLAB) Falls Nearly 5% as Selling Pressure Tests Key SupportLate Stage Breakouts - newsline.com
Insider Sell: Brian Archbold Sells Shares of Mesa Laboratories I - GuruFocus
Mesa Laboratories CAO Lyndsey Crennen sells $11,949 in shares By Investing.com - Investing.com South Africa
Mesa Laboratories Inc (MLAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mesa Laboratories SVP Brian Archbold sells $116,558 in shares - Investing.com UK
Mesa Laboratories Inc (MLAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mesa Laboratories SVP Brian Archbold sells $116,558 in shares By Investing.com - Investing.com Nigeria
Mesa Labs CFO John Sakys sells $123,849 of company stock By Investing.com - Investing.com Canada
Mesa Labs CFO John Sakys sells $123,849 of company stock - Investing.com UK
Finanzdaten der Mesa Laboratories Inc-Aktie (MLAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mesa Laboratories Inc-Aktie (MLAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Crennen Lyndsey Elizabeth | CAO |
Jun 22 '26 |
Sale |
89.50 |
442 |
39,560 |
2,020 |
| Archbold Brian David | SVP Operations |
Jun 18 '26 |
Option Exercise |
95.10 |
3,324 |
316,112 |
7,034 |
| Archbold Brian David | SVP Operations |
Jun 22 '26 |
Sale |
89.50 |
2,516 |
225,187 |
6,377 |
| Sakys John | CFO |
Jun 18 '26 |
Option Exercise |
95.10 |
3,792 |
360,619 |
20,330 |
| Sakys John | CFO |
Jun 22 '26 |
Sale |
89.50 |
2,827 |
253,022 |
19,785 |
2.60%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):